Intervención farmacéutica en la prescripción de metformina en pacientes con diabetes mellitus tipo 2 e insuficiencia renal

Nathan, 2009, Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, 32, 193, 10.2337/dc08-9025 Menéndez Torre, 2010, Recomendaciones para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2: documento de consenso, Av Diabetol, 26, 331, 10.1016/S1134-3230(10)65006-5 Lalau, 1999, Lactic acidosis in metformin-treated patients: Prognostic value of arterial lactate levels and plasma metformin concentrations, Drug Saf, 20, 377, 10.2165/00002018-199920040-00006 Stang, 1999, Incidence of lactic acidosis in metformin users, Diabetes Care, 22, 925, 10.2337/diacare.22.6.925 Misbin, 2004, The phantom of lactic acidosis due to metformin in patients with diabetes, Diabetes Care, 27, 1791, 10.2337/diacare.27.7.1791 Lalau, 2010, Lactic acidosis induced by metformin: Incidence, management and prevention, Drug Saf, 33, 727, 10.2165/11536790-000000000-00000 García F, Rodríguez M, Malo F, Vázquez F, Modroño M, Fluiters E, et al. Guías clínicas-diabetes mellitus tipo 2. Atención Primaria en la Red. [consultado 1 Sep 2013]. Disponible en: http://www.fisterra.com/guias-clinicas/diabetes-mellitus-tipo-2/ Handelsman, 2011, American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan, Endocr Pract, 17, S1, 10.4158/EP.17.S2.1 Harper, 2008, Pharmacologic management of type 2 diabetes. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Can J Diabetes, 32, S53 Institute for Safe Medication Practices. ISMP’ list of high-alert medications. Huntingdon Valley (PA): ISMP; 2012. [consultado 1 Sep 2013]. Disponible en: http://www.ismp.org/Tools/highalertmedications.pdf McCormack, 2005, Metformin's contraindications should be contraindicated, CMAJ, 173, 502, 10.1503/cmaj.045292 Holstein, 2005, Contraindications can damage your health: Is metformin a case in point?, Diabetologia, 48, 2454, 10.1007/s00125-005-0026-1 Tahrani, 2007, Metformin, heart failure, and lactic acidosis: Is metformin absolutely contraindicated?, BMJ, 335, 508, 10.1136/bmj.39255.669444.AE Carral San Laureano, 2010, Metformina y acidosis láctica: ¿asociación infrecuente o casualidad?, Av Diabetol, 26, 273, 10.1016/S1134-3230(10)64015-X Salpeter, 2003, Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus, Arch Intern Med, 163, 2594, 10.1001/archinte.163.21.2594 Gjedde, 2003, Survival following a metformin overdose of 63g: A case report, Pharmacol Toxicol, 93, 98, 10.1034/j.1600-0773.2003.930207.x Lalau, 2005, Unexpected recovery from prolonged hypoglycemic coma: A protective role of metformin?, Intensive Care Med, 31, 493, 10.1007/s00134-004-2540-x Knaus, 1991, The APACHE III prognostic system: Risk prediction of hospital mortality for critically ill hospitalized adults, Chest, 100, 1619, 10.1378/chest.100.6.1619 Ahmad, 2002, Recovery from pH 6.38: Lactic acidosis complicated by hypothermia, Emerg Med J, 19, 169, 10.1136/emj.19.2.169 Dell’Aglio, 2009, Acute metformin overdose: Examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: A systematic review of the literature, Ann Emerg Med, 54, 818, 10.1016/j.annemergmed.2009.04.023 Eurich, 2005, Improved clinical outcomes associated with metformin in patients with diabetes and heart failure, Diabetes Care, 28, 2345, 10.2337/diacare.28.10.2345 Lalau, 1990, Type 2 diabetes in the elderly: An assessment of metformin, Int J Clin Pharmacol Ther Toxicol, 28, 329 Ruano, 2012, Adecuación de la farmacoterapia en insuficiencia renal: Utilidad de la prescripción electrónica, Aten Farm, 14, 27 Estellat, 2007, Impact of pharmacy validation in a computerized physician order entry context, Int J Qual Health Care, 19, 317, 10.1093/intqhc/mzm025 Vélez-Díaz-Pallarés, 2013, Using health care failure mode and effect analysis to reduce medication errors in the process of drug prescription, validation and dispensing in hospitalised patients, BMJ Qual Saf, 22, 42, 10.1136/bmjqs-2012-000983 Grizzle, 2007, Reasons provided by prescribers when overriding drug-drug interaction alerts, Am J Manag Care, 13, 573 Phansalkar, 2010, A review of human factors principles for the design and implementation of medication safety alerts in clinical information systems, J Am Med Inform Assoc, 17, 493, 10.1136/jamia.2010.005264 Pozo-Fernández, 2012, Discrepancias entre documentos de consenso, guías, práctica clínica y normativa legal en el tratamiento de los pacientes con diabetes mellitus tipo 2, Nefrologia, 32, 367 Barnett, 2010, Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy, Curr Med Res Opin, 26, 1333, 10.1185/03007991003738063